A

Arlington Research Center, Inc. | Arlington, TX

Research site
(Unclaimed)
Location
711 E Lamar Boulevard, Suite 200, Arlington, Texas, United States of America
Site insights

Top conditions

Atopic Dermatitis (8 trials)

Dermatitis (8 trials)

Eczema (8 trials)

Psoriasis (8 trials)

Acne Vulgaris (2 trials)

Top treatments

PF-04965842
CP-690,550
JNJ-77242113
Difamilast
Pregabalin
ACZONE
Dapsone
Lebrikizumab
IDP-107
122-0551

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 21
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

This is a Phase 3, open-label study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate AD....

Active, not recruiting
Atopic Dermatitis
Drug: Difamilast

The purpose of the study is to see how effective JNJ-77242113 is in participants with plaque psoriasis affecting special areas (scalp, genital, and/o...

Enrolling
Plaque Psoriasis
Drug: JNJ-77242113
Drug: Placebo

The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.

Enrolling
Plaque Psoriasis
Drug: JNJ-77242113
Drug: Placebo
Locations recently updated

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 100 mg
Drug: Placebo

Trial sponsors

Pfizer logo

Pfizer (8 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems